Summary of project PR001346
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001346. The data can be accessed directly via it's Project DOI: 10.21228/M8QX47 This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
| Project ID: | PR001346 |
| Project DOI: | doi: 10.21228/M8QX47 |
| Project Title: | Functional metabolic molecule were identified as novel therapeutic targets to facilitate gemcitabine treatment against pancreatic cancer |
| Project Type: | Targeted MS quantitative analysis |
| Project Summary: | Characteristics of pancreatic cancer metabolomics with gemcitabine treatment |
| Institute: | Shanghai Center for Systems Biomedicine, Shanghai Jiaotong University |
| Department: | Shanghai Center for Systems Biomedicine |
| Laboratory: | Lu Group |
| Last Name: | Lu |
| First Name: | Haitao |
| Address: | 800 Dongchuan RD. Minhang District, Shanghai, Shanghai, 200240, China |
| Email: | haitao_lu@sjtu.edu.cn |
| Phone: | 15221478139 |
Summary of all studies in project PR001346
| Study ID | Study Title | Species | Institute | Analysis(* : Contains Untargted data) | Release Date | Version | Samples | Download(* : Contains raw data) |
|---|---|---|---|---|---|---|---|---|
| ST002121 | Functional metabolic molecule were identified as novel therapeutic targets to facilitate gemcitabine treatment against pancreatic cancer (Tumor tissues metabolomics) | Mus musculus | Shanghai Center for Systems Biomedicine, Shanghai Jiaotong University | MS | 2022-04-20 | 1 | 12 | Uploaded data (37.9M)* |
| ST002122 | Functional metabolic molecules were identified as novel therapeutic targets to facilitate gemcitabine treatment against pancreatic cancer (Cells metabolomics) | Homo sapiens | Shanghai Center for Systems Biomedicine, Shanghai Jiaotong University | MS | 2022-04-20 | 1 | 15 | Uploaded data (10M)* |
| ST002255 | Functional metabolic molecules were identified as novel therapeutic targets to facilitate gemcitabine treatment against pancreatic cancer (Cells metabolomics with ATP) | Homo sapiens | Shanghai Center for Systems Biomedicine, Shanghai Jiaotong University | MS | 2022-08-22 | 1 | 10 | Uploaded data (6.7M)* |
